OUR FOOTPRINT - TERRITORIES
- Headquartered in Athens, Specialty Therapeutics has long expertise of commercialization of Oncology/Haematology, Gynecology/Endocrinology, Respiratory and Rare (Orphan) Diseases products not only in Greece but also in Balkan and Eastern Europe countries. (13 countries, 66 million population, 3rd biggest region in Europe)
- Specialty Therapeutics’ team is built by successful and respected professionals with strong commercial capabilities, proven track record of commercial success of Oncology/Haematology, Gynecology/Endocrinology, Respiratory and Rare (Orphan) Diseases area, committed to bring innovative therapies to the patients with Oncological/ Haematological, Gynecological, Respiratory & Rare (Orphan) Diseases.
- Specialty Therapeutics offers two options of partnership/collaboration
- Local: Greece and Cyprus
- Regional: Greece, Cyprus, Balkan and Eastern Europe Countries
Presence in 13 countries with ~66m population (3rd biggest territory in Europe)
EU RANK |
No |
COUNTRY |
POPULATION |
EU STATUS |
9 |
1 |
Romania |
21.529.967 |
Member country of the EU |
13 |
2 |
Greece - Central offices |
10.768.477 |
Member country of the EU |
20 |
3 |
Serbia |
7.111.024 |
Candidate country |
21 |
4 |
Bulgaria |
7.101.510 |
Member country of the EU |
28 |
5 |
Croatia |
4.292.095 |
Member country of the EU |
29 |
6 |
Bosnia and Herzegovina |
3.856.181 |
Potential candidate |
31 |
7 |
Albania |
3.047.987 |
Candidate country |
34 |
8 |
North Macedonia |
2.103.721 |
Candidate country |
35 |
9 |
Slovenia |
1.972.126 |
Member country of the EU |
37 |
10 |
Kosovo |
1.895.250 |
Potential candidate |
39 |
11 |
Cyprus |
1.221.549 |
Member country of the EU |
40 |
12 |
Montenegro |
642.550 |
Candidate country |
42 |
13 |
Malta |
416.338 |
Member country of the EU |
|
|
Therapeutics - Group of Companies footprint = 14% |
65.958.775 |
|
|